313 related articles for article (PubMed ID: 28745824)
1. Gemcitabine combined with cisplatin as adjuvant chemotherapy for non-small cell lung cancer: A retrospective analysis.
Ma D; Wang J; Hao X; Wang Y; Hu X; Xing P; Li J
Thorac Cancer; 2017 Sep; 8(5):482-488. PubMed ID: 28745824
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin plus gemcitabine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: a pilot study.
Tibaldi C; Mazzoni E; Arcabasso G; D'Incecco A; Antonuzzo A; Menconi G; Falcone A
Clin Lung Cancer; 2009 Jan; 10(1):53-7. PubMed ID: 19289373
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.
Scagliotti GV; Pastorino U; Vansteenkiste JF; Spaggiari L; Facciolo F; Orlowski TM; Maiorino L; Hetzel M; Leschinger M; Visseren-Grul C; Torri V
J Clin Oncol; 2012 Jan; 30(2):172-8. PubMed ID: 22124104
[TBL] [Abstract][Full Text] [Related]
4. Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer.
Yamaguchi M; Takeo S; Suemitsu R; Matsuzawa H
Cancer Chemother Pharmacol; 2010 May; 66(1):107-12. PubMed ID: 19809815
[TBL] [Abstract][Full Text] [Related]
5. Feasibility study of adjuvant chemotherapy with gemcitabine and split-dose cisplatin for completely resected non-small-cell lung cancer.
Funai K; Takamochi K; Itaya T; Mochizuki T; Nakamura T; Toyoda F; Yong-Il K; Sasaki K; Momiki S; Takahashi T; Neyatani H; Suzuki K
Lung Cancer; 2010 Apr; 68(1):78-83. PubMed ID: 19570590
[TBL] [Abstract][Full Text] [Related]
6. A phase II, open-label trial of bortezomib (VELCADE(®)) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer.
Kontopodis E; Kotsakis A; Kentepozidis N; Syrigos K; Ziras N; Moutsos M; Filippa G; Mala A; Vamvakas L; Mavroudis D; Georgoulias V; Agelaki S
Cancer Chemother Pharmacol; 2016 May; 77(5):949-56. PubMed ID: 26994909
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).
Van Zandwijk N; Smit EF; Kramer GW; Schramel F; Gans S; Festen J; Termeer A; Schlosser NJ; Debruyne C; Curran D; Giaccone G
J Clin Oncol; 2000 Jul; 18(14):2658-64. PubMed ID: 10894864
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.
Cappuzzo F; Selvaggi G; Gregorc V; Mazzoni F; Betti M; Rita Migliorino M; Novello S; Maestri A; De Marinis F; Darwish S; De Angelis V; Nelli F; Bartolini S; Scagliotti GV; Tonato M; Crinò L
Cancer; 2003 Jul; 98(1):128-34. PubMed ID: 12833465
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine/cisplatin as induction therapy for stage IIIA N2 non-small-cell lung cancer.
Scagliotti GV
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):15-9. PubMed ID: 10960940
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: a phase II study.
Aydiner A; Kiyik M; Cikrikcioglu S; Kosar F; Gurses A; Turna A; Yazar A; Dilege S; Goksel T; Cakan A
Lung Cancer; 2007 Nov; 58(2):246-52. PubMed ID: 17683827
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma.
Rodriguez J; Cortes J; Calvo E; Azinovic I; Fernandez-Hildago O; Martinez-Monge R; Garzon C; de Irala J; Martinez-Aguillo M; Ramon Y Cajal T; Brugarolas A
Cancer; 2000 Dec; 89(12):2622-9. PubMed ID: 11135224
[TBL] [Abstract][Full Text] [Related]
12. Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2
Zhong WZ; Chen KN; Chen C; Gu CD; Wang J; Yang XN; Mao WM; Wang Q; Qiao GB; Cheng Y; Xu L; Wang CL; Chen MW; Kang X; Yan W; Yan HH; Liao RQ; Yang JJ; Zhang XC; Zhou Q; Wu YL
J Clin Oncol; 2019 Sep; 37(25):2235-2245. PubMed ID: 31194613
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine combined with cisplatin as neoadjuvant chemotherapy in stage IB-IIIA non-small cell lung cancer.
Davidov MI; Polotzky BE; Marenich AF; Orlov SV; Lazarev AF; Skryabina LS; Pavlushkov EV; Semenchenya VA; Brichkova OY; Karaseva VV
Anticancer Drugs; 2011 Jul; 22(6):569-75. PubMed ID: 21487288
[TBL] [Abstract][Full Text] [Related]
14. A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for Stage III non-small cell lung cancer.
Migliorino MR; De Marinis F; Nelli F; Facciolo F; Ammaturo MV; Cipri A; Belli R; Ariganello O; Diana F; Di Molfetta M; Martelli O
Lung Cancer; 2002 Mar; 35(3):319-27. PubMed ID: 11844608
[TBL] [Abstract][Full Text] [Related]
15. A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study.
Rossi D; Graziano F; Catalano V; Giordani P; Fedeli SL; Alessandroni P; Fedeli A; Dennetta D; Ugolini M; Catalano G
Anticancer Res; 2002; 22(5):3087-92. PubMed ID: 12530048
[TBL] [Abstract][Full Text] [Related]
16. A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma.
Ricci S; Antonuzzo A; Galli L; Tibaldi C; Bertuccelli M; Lopes Pegna A; Petruzzelli S; Bonifazi V; Orlandini C; Franco Conte P
Cancer; 2000 Oct; 89(8):1714-9. PubMed ID: 11042565
[TBL] [Abstract][Full Text] [Related]
17. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
[TBL] [Abstract][Full Text] [Related]
18. Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling.
Huisman C; Giaccone G; van Groeningen CJ; Sutedja G; Postmus PE; Smit EF
Lung Cancer; 2001; 33(2-3):267-75. PubMed ID: 11551422
[TBL] [Abstract][Full Text] [Related]
19. A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer.
Lv C; Ma Y; Wu N; Yan S; Zheng Q; Sun Y; Li S; Fang J; Yang Y
World J Surg Oncol; 2013 Mar; 11():76. PubMed ID: 23517534
[TBL] [Abstract][Full Text] [Related]
20. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
Wang J; Wu N; Lv C; Yan S; Yang Y
J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]